Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Emoform Glic is a specialized oral care line comprising toothpaste and mouthwash formulated to support periodontal health and manage gingival inflammation. The products feature the **Lactoferrin Barrier Complex (LBC)** as the primary active component. Lactoferrin is a multifunctional glycoprotein known for its antimicrobial, anti-inflammatory, and immunomodulatory properties. Its mechanism involves sequestering free iron, which is essential for the growth of many pathogenic bacteria, and directly interacting with bacterial lipopolysaccharides to disrupt cell membranes. Emoform Glic is particularly targeted toward individuals with increased susceptibility to gingivitis, such as pregnant women, to help stabilize the oral microbiota and protect against pregnancy-associated periodontal disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Emoform Glic.